Axillary lymph-node metabolic activity assessment on 18F-FDG-PET/CT in rheumatoid arthritis patients treated with biologic therapies
暂无分享,去创建一个
Y. Tsushima | T. Nakajima | H. Chikuda | Y. Arisaka | Y. Yonemoto | K. Okamura | T. Suto | T. Tajika | H. Tomonaga | M. Tachibana | TT Dam | LD Vu
[1] Y. Tsushima,et al. Predictive factors related to shoulder joint destruction in rheumatoid arthritis patients treated with biologics: A prospective study , 2017, Modern rheumatology.
[2] Y. Tsushima,et al. Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis , 2017, Medicine.
[3] Y. Tsushima,et al. Effect of total knee arthroplasty on other joints in patients with rheumatoid arthritis evaluated by 18‐FDG‐PET , 2017, International journal of rheumatic diseases.
[4] G. Firestein,et al. Immunopathogenesis of Rheumatoid Arthritis. , 2017, Immunity.
[5] R. Caporali,et al. Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors , 2016, Arthritis Research & Therapy.
[6] Y. Tsushima,et al. Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score , 2016, Medicine.
[7] E. Schwarz,et al. Relationship Between Lymph Node Volume and Pain Following Certolizumab Therapy for Rheumatoid Arthritis Flare: A Pilot Study , 2016, Clinical medicine insights. Arthritis and musculoskeletal disorders.
[8] M. Biermann,et al. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients , 2015, The Journal of Nuclear Medicine.
[9] Y. Tsushima,et al. Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT , 2014, BMC Musculoskeletal Disorders.
[10] R. Caporali,et al. B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers , 2014, BioMed research international.
[11] A. Salavati,et al. FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[12] S. Basu,et al. Regional Lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement , 2014, Rheumatology International.
[13] P. Tak,et al. The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis , 2013, Annals of the rheumatic diseases.
[14] S. Basu,et al. Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies. , 2012, World journal of radiology.
[15] Y. Tsushima,et al. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT. , 2012, Rheumatology.
[16] R. Caporali,et al. Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography. , 2011, Rheumatology.
[17] E. Schwarz,et al. Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. , 2011, Arthritis and rheumatism.
[18] Alaor Barra Sobrinho,et al. Extra-articular inflammatory sites detected by F-18 FDG PET/CT in a patient with rheumatoid arthritis. , 2010, Clinical nuclear medicine.
[19] J. Li,et al. Expanded CD23+/CD21hi B Cells in Inflamed Lymph Nodes Are Associated with the Onset of Inflammatory-Erosive Arthritis in TNF-Transgenic Mice and Are Targets of Anti-CD20 Therapy , 2010, The Journal of Immunology.
[20] P. V. van Riel,et al. The Disease Activity Score and the EULAR response criteria , 2009 .
[21] K. Kubota,et al. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints , 2009, Annals of nuclear medicine.
[22] K. Ohtomo,et al. Inflammatory Cytokines and Hypoxia Contribute to 18F-FDG Uptake by Cells Involved in Pannus Formation in Rheumatoid Arthritis , 2009, Journal of Nuclear Medicine.
[23] M. O. Papuga,et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. , 2007, Arthritis and rheumatism.
[24] C. Beck,et al. MRI and Quantification of Draining Lymph Node Function in Inflammatory Arthritis , 2007, Annals of the New York Academy of Sciences.
[25] R. Caporali,et al. B cells in rheumatoid arthritis. , 2007, Autoimmunity reviews.
[26] D. W. Seldin,et al. Axillary Lymph Node Visualization on F-18 FDG PET Body Scans in Patients With Rheumatoid Arthritis , 2007, Clinical nuclear medicine.
[27] V. Treyer,et al. F-18 FDG Whole-Body PET for the Assessment of Disease Activity in Patients With Rheumatoid Arthritis , 2006, Clinical nuclear medicine.
[28] R. Hustinx,et al. Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] Shigehiro Sato,et al. Augmentation effects of lymphocyte activation by antigen-presenting macrophages on FDG uptake , 2003, Annals of nuclear medicine.
[30] A. Akdoğan,et al. Frequency of Lymphadenopathy in Rheumatoid Arthritis and Systemic Lupus Erythematosus , 2003, The Journal of international medical research.
[31] C. Berek,et al. B cells in rheumatoid arthritis , 2000, Arthritis research.
[32] P. Bacon,et al. Rheumatoid lymphadenopathy: a morphological and immunohistochemical study. , 1990, Journal of clinical pathology.
[33] R. Williams,et al. Immunocytological studies of lymph nodes in rheumatoid arthritis and malignant lymphoma. , 1980, Annals of the rheumatic diseases.
[34] J. Nosanchuk,et al. Follicular hyperplasia in lymph nodes from patients with rheumatoid arthritis. A clinicopathologic study , 1969, Cancer.
[35] Y. Tsushima,et al. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis , 2015, Rheumatology International.
[36] J. Li,et al. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. , 2013, Arthritis and rheumatism.